INVO Fertility, Inc.
NASDAQIVF (INVO Fertility) reports Q1 2026 results on May 22 as one of the most financially distressed micro-caps on Nasdaq — the setup is less about short pressure and more about whether the company can show any sign of operational stabilisation. The borrow market tells a more complicated story than the headline short interest. At just 0.74% of the free float, short interest is…
IVF short interest surges 39% in one week to 0.65% of float, cost to borrow falls to 53.7% as stock drops 14.7% weekly.
Snapshot as of 22 Jun 2026
IVF (INVO Fertility) reports Q1 2026 results on May 22 as one of the most financially distressed micro-caps on Nasdaq — the setup is less about short pressure and more about whether the company can show any sign of…
IVF arrives at its April 30 earnings with the stock down 28% over the past month — a selloff that has reset the bar sharply lower but has also driven a notable shift in borrowing conditions. The most interesting angle…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for IVF — free to start on ORTEX.
Sign up for free →Open IVF on ORTEX